BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33425767)

  • 1. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma.
    Reni M; Andreasi V; Gasparri AM; Dugnani E; Colombo B; Macchini M; Bianco M; Dallatomasina A; Citro A; Assi E; Protti MP; Esposito A; Falconi M; Curnis F; Piemonti L; Corti A
    Front Oncol; 2020; 10():613582. PubMed ID: 33425767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor growth by circulating full-length chromogranin A.
    Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
    Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
    Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
    Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression.
    Chowdhury NN; Yang Y; Dutta A; Luo M; Wei Z; Abrahams SR; Revenko AS; Shah F; Miles LA; Parmer RJ; de Laat B; Wolberg AS; Luyendyk JP; Fishel ML; Flick MJ
    Mol Oncol; 2024 Jan; 18(1):113-135. PubMed ID: 37971174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.
    Bianco M; Gasparri AM; Colombo B; Curnis F; Girlanda S; Ponzoni M; Bertilaccio MT; Calcinotto A; Sacchi A; Ferrero E; Ferrarini M; Chesi M; Bergsagel PL; Bellone M; Tonon G; Ciceri F; Marcatti M; Caligaris-Cappio F; Corti A
    Cancer Res; 2016 Apr; 76(7):1781-91. PubMed ID: 26869462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.
    Parmer RJ; Mahata M; Gong Y; Mahata SK; Jiang Q; O'Connor DT; Xi XP; Miles LA
    J Clin Invest; 2000 Oct; 106(7):907-15. PubMed ID: 11018079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
    Jiang Q; Taupenot L; Mahata SK; Mahata M; O'Connor DT; Miles LA; Parmer RJ
    J Biol Chem; 2001 Jul; 276(27):25022-9. PubMed ID: 11342539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
    Mahata SK; Corti A
    Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion.
    Colombo B; Longhi R; Marinzi C; Magni F; Cattaneo A; Yoo SH; Curnis F; Corti A
    J Biol Chem; 2002 Nov; 277(48):45911-9. PubMed ID: 12297497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin-A production and fragmentation in patients with Takayasu arteritis.
    Tombetti E; Colombo B; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bozzolo EP; Tombolini E; Benedetti G; Godi C; Lanzani C; Rovere-Querini P; Del Maschio A; Ambrosi A; De Cobelli F; Sabbadini MG; Baldissera E; Corti A; Manfredi AA
    Arthritis Res Ther; 2016 Aug; 18():187. PubMed ID: 27531191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma.
    Lee SH; Jo JH; Kim YJ; Lee HS; Chung MJ; Park JY; Bang S; Park SW; Song SY
    Pancreas; 2019; 48(5):662-669. PubMed ID: 31091213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
    Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
    Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new chromogranin A-dependent angiogenic switch activated by thrombin.
    Crippa L; Bianco M; Colombo B; Gasparri AM; Ferrero E; Loh YP; Curnis F; Corti A
    Blood; 2013 Jan; 121(2):392-402. PubMed ID: 23190532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
    Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
    Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
    Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
    Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage.
    Ferrero E; Scabini S; Magni E; Foglieni C; Belloni D; Colombo B; Curnis F; Villa A; Ferrero ME; Corti A
    FASEB J; 2004 Mar; 18(3):554-6. PubMed ID: 14734634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
    PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
    Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
    Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
    Stridsberg M; Angeletti RH; Helle KB
    J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A and the endothelial barrier function.
    Corti A; Ferrero E
    Curr Med Chem; 2012; 19(24):4051-8. PubMed ID: 22834794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.